Pharmaceutical composition for treating chronic urticaria

Abstract

The invention relates to a pharmaceutical composition for treating chronic urticaria. The pharmaceutical composition is prepared from the following medicinal raw materials in parts by weight: 150-200 parts of garden balsam herb, 100-150 parts of lithospermum arvense, 130-180 parts of hemistepta lyrata, 100-150 parts of glechoma longituba, 130-190 parts of pampanin shuteria herb, 100-150 parts of semen allii tuberose, 100-150 parts of sassafras, 100-150 parts of caulis spatholobi, 50-100 parts of bile arisaema, 50-100 parts of raspberries, 50-100 parts of fructus aurantii, 100-150 parts of funaria hygrometrica, 50-100 parts of polygonum cuspidatum, 150-200 parts of bauhinia championii, 130-170 parts of heliotropium indicum, 100-150 parts of wolfberry fruits, 150-200 parts of ipomoea pes-caprae, 80-130 parts of longans, 100-150 parts of lepisori herba, 80-120 parts of garden balsam stems, 50-80 parts of storax, 30-70 parts of spina gleditsiae, 100-150 parts of ainsliaefolious cacalia roots and 100-150 parts of liquorice. The pharmaceutical composition for treating chronic urticaria provided by the invention is reasonable in formula and has the characteristics of exact in curative effect, safe and convenient, free of toxic and side effects and low in cost.

Description

technical field

[0001] The invention relates to the field of medicine, in particular to a pharmaceutical composition for treating chronic urticaria. Background technique

[0002] Urticaria is a kind of allergic skin disease, is called " rubella group " by people. Clinically, there are often acute and chronic urticaria, and the general course of disease is considered to be chronic urticaria if it exceeds 8 weeks. And chronic urticaria often shows effect repeatedly, protracted and difficult to heal, brings huge misery to the patient. There are many ways to treat chronic urticaria. Western medicine generally adopts antihistamines and glucocorticoids. Although they can temporarily control symptoms, the recurrence rate is high. Contents of the invention

[0003] The purpose of the present invention is to provide a pharmaceutical composition for treating chronic urticaria.

[0004] In order to realize the object of the present invention, the present invention provides a kind ...